Steroid-Free Remission in Adalimumab-Treated Pediatric Patients With Moderately to Severely Active Crohn's Disease in the IMAgINE 1 Trial

被引:0
|
作者
Griffiths, Anne M.
Crandall, Wallace
Colletti, Richard B.
Ruemmele, Frank
Faubion, William A.
Hyams, Jeffrey S.
Lazar, Andreas
Li, Yao
Eichner, Samantha
Thakkar, Roopal
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1151
引用
收藏
页码:S213 / S213
页数:1
相关论文
共 50 条
  • [41] Maintenance of Long-Term Remission in Patients with Moderately to Severely Active Crohn's Disease Treated for 3 Years with Adalimumab: Results from the Open-Label ADHERE Study
    Rutgeerts, Paul
    Colombel, Jean-Frederic
    Sandborn, William J.
    Rutgeerts, Paul J.
    D'Haens, Geert R.
    Lomax, Kathleen G.
    Li, Ju
    Pollack, Paul F.
    GASTROENTEROLOGY, 2009, 136 (05) : A652 - A652
  • [42] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
    Thin, L.
    Dubinsky, M.
    D'Haens, G.
    Dewit, O.
    Juillerat, P.
    Panaccione, R.
    Fujii, T.
    Lacerda, A.
    Dubcenco, E.
    Anyanwu, S.
    Doshi, C.
    Mallick, M.
    Garrison, A.
    Liu, J.
    Loftus, E., Jr.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 127 - 128
  • [43] CORTICOSTEROID DISCONTINUATION AND CLINICAL OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE TREATED WITH UPADACITINIB
    Dubinsky, Marla C.
    D'Haens, Geert
    Dewit, Olivier
    Juillerat, Pascal
    Panaccione, Remo
    Fujii, Toshimitsu
    Lacerda, Ana P.
    Dubcenco, Elena
    Anyanwu, Samuel
    Doshi, Chirag
    Mallick, Madhuja
    Garrison, Andrew
    Liu, Jianzhong
    Loftus, Edward V.
    GASTROENTEROLOGY, 2023, 164 (06) : S1087 - S1088
  • [44] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
    Dubinsky, Marla C.
    D'Haens, Geert
    Dewit, Olivier
    Juillerat, Pascal
    Panaccione, Remo
    Fujii, Toshimitsu
    Lacerda, Ana P.
    Dubcenco, Elena
    Anyanwu, Samuel
    Doshi, Chirag
    Mallick, Madhuja
    Garrison, Andrew
    Liu, John
    Loftus, Edward V., Jr.
    SWISS MEDICAL WEEKLY, 2023, 153 : 9S - 10S
  • [45] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
    Dubinsky, M. C.
    D'Haens, G.
    Dewit, O.
    Juillerat, P.
    Panaccione, R.
    Fujii, T.
    Lacerda, A. P.
    Dubcenco, E.
    Anyanwu, S.
    Doshi, C.
    Mallick, M.
    Garrison, A.
    Liu, J.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I104 - I106
  • [46] Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
    Schreiber, S.
    Reinisch, W.
    Colombel, J. F.
    Sandborn, W. J.
    Hommes, D. W.
    Robinson, A. M.
    Huang, B.
    Lomax, K. G.
    Pollack, P. F.
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (03): : 213 - 221
  • [47] Adalimumab maintains long-term remission in moderately to severely active Crohn's disease after infliximab failure: 1-year follow-up of gain trial
    Panaccione, Remo
    Sandbom, William J.
    D'Haens, Geert
    Enns, Robert A.
    Wolf, Douglas C.
    Lomax, Kathleen G.
    Pollack, Paul F.
    GASTROENTEROLOGY, 2008, 134 (04) : A133 - A134
  • [48] Adalimumab maintains clinical remission and response in patients with active Crohn's disease: Results of the CHARM trial
    Sandborn, William J.
    Colombel, J. F.
    Rutgeerts, P.
    Enns, R.
    Hanauer, S. B.
    Panaccione, R.
    Schreiber, S.
    Lomax, K. G.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S458 - S458
  • [49] Adalimumab Therapy maintains remission for up to 3 Years in patients with moderately to severely active Crohn's Disease: Results From an Open-Label Extension of CHARM
    Panaccione, R.
    Colombel, J.
    Sandborn, W.
    Rutgeerts, P.
    D'Haens, G.
    Lomax, K.
    Li, J.
    Pollack, P.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S43 - S43
  • [50] Crohn's Disease Mucosal Healing in Adalimumab-Treated Patients is Affected by Disease Duration: Results From Extend
    Sandborn, William J.
    Panaccione, Remo
    Thakkar, Roopal
    Lomax, Kathleen G.
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    Yang, Mei
    GASTROENTEROLOGY, 2010, 138 (05) : S164 - S164